poz.comPOZ - Health, Life and HIV - POZ

You are currently logged into POZ Directory - My Account or Log Out Home Basics Basics Introduction HIV Transmission and Risks HIV Testing HIV Prevention Newly Diagnosed Starting HIV Treatment HIV Medications HIV Drug Assistance Programs HIV/HCV Coinfection VIH/SIDA en Español News News Newsfeed Treatment News Features Opinions Conferences Slideshows Videos POZ TV POZ Stories POZ 100 By Author RSS Links Hot Topics Hot Topics Coronavirus (COVID-19) POZ Awards POZ at 25 POZ 100 Advocacy Cure Undetectable (U=U) Prevention PrEP Criminalization Newly Diagnosed Long-Term Survivors Youth Magazine Magazine Current Issue Archives Digital Editions POZ Focus Subscriptions Email Newsletters Blogs Blogs Recent Posts Browse Bloggers RSS Links Community Community POZ Personals POZ Stories POZ 100 Community AIDS Is Everyday Forums Polls Surveys Quizzes Ask POZ Services Directory Calendar Jobs Bookstore About Us About Us About Us Masthead Awards Press Releases Advertise Contact Us Facebook Twitter © 2020 Smart + Strong . All Rights Reserved. Terms of use and Your privacy . Smart + Strong ® is a registered trademark of CDM Publishing, LLC. © 2020 Smart + Strong . All Rights Reserved. Terms of use and Your privacy . Smart + Strong ® is a registered trademark of CDM Publishing, LLC. Advertisement Updates From the 2020 Conference on Retroviruses and Opportunistic Infections UPDATED: What People With HIV Need to Know About the New Coronavirus Click Here for the Current Issue of POZ Updates From the 2020 Conference on Retroviruses and Opportunistic Infections UPDATED: What People With HIV Need to Know About the New Coronavirus Click Here for the Current Issue of POZ My Pet Virus and Our Pet Coronavirus #COVIDー19 Reagan was vicious in his silent treatment of the HIV epidemic, but Trump’s lips and zipper have the same problem: he can’t keep either shut Understanding the Challenges Facing Long-Term Survivors Researchers are addressing issues of longevity in older people living with HIV. Creating Opportunities for Trans Women of Color to Thrive An interview with Jasmine Tasaki of We Care Tennessee Massive Display of AIDS Quilt in San Francisco to Be Rescheduled In other AIDS Memorial news: Applications are being accepted for the Mary Bowman arts award and the Pedro Zamora youth scholarship. Method of Prompting Body to Develop Strong HIV Antibodies Shows Early Promise Researchers used a harmless virus to deliver a gene for a broadly neutralizing HIV antibody to cells, which produced the antibody over time. MUST read Discover Nelson’s Trogarzo® Experience [SPONSORED] POZ Focus - How Did HIV Change Your Life? UPDATED: What People With HIV Need to Know About the New Coronavirus The Truth About the 7,000 Mark S. King: I Wrote “The Truth About the 7,000.” Now What? Listen Now: Signorile and King Discuss “The Truth About the 7,000” #African American #Latino #Women From Here To... October? Why Public Health Folks Are Routing For a Long, Slow Epidemic New model of U.S. coronavirus spread suggests July peak Yes, Kids Can Get the New Coronavirus Children can contract the virus, although they usually have no symptoms or mild illness. From the Dark Days of AIDS Arrives an Unexpected Gift How a young man who died in 1995 helps HIV-positive students attend college today An HIV Update From “the Overdose Capital of America” What has happened since health experts identified an HIV cluster in Huntington, West Virginia, in 2018? FDA’s 12-Month Deferral for Gay Blood Donors Not Tied to Higher HIV Rate Researchers compared the rate of first-time blood donors who tested positive for HIV before and after the new deferral policy. Hot topics Forums: Support and discussion Blogs: The community speaks POZ Stories: Get inspired Magazine: Search the archives HIV: The Basics Recursos de VIH/SIDA en Español AIDS Is Everyday Ask POZ WHO Declares Novel Coronavirus Outbreak a Pandemic. Now What? Four key ways countries can prevent infections, save lives and minimize impact Clinics Need to Increase HIV and Hep C Testing for People Who Inject Drugs A recent analysis found that health care providers missed opportunities to test 90% of such patients. Long-Acting HIV Regimen Cabenuva Is Effective With Dosing Every 8 Weeks Whether given every four or eight weeks, long-acting injections of cabotegravir and rilpivirine suppressed HIV equally well. People Who Start HIV Treatment Early Have a Normal Life Expectancy But even starting antiretrovirals with a high CD4 count doesn’t close the wide gap in years lived without major health problems. Advertisement Newsfeed Massive Display of AIDS Quilt in San Francisco to Be Rescheduled Yes, Kids Can Get the New Coronavirus An HIV Update From “the Overdose Capital of America” WHO Declares Novel Coronavirus Outbreak a Pandemic. Now What? Watch Out for These Coronavirus and HIV Email Scams Treatment News UPDATED: What People With HIV Need to Know About the New Coronavirus Method of Prompting Body to Develop Strong HIV Antibodies Shows Early Promise FDA’s 12-Month Deferral for Gay Blood Donors Not Tied to Higher HIV Rate Clinics Need to Increase HIV and Hep C Testing for People Who Inject Drugs Long-Acting HIV Regimen Cabenuva Is Effective With Dosing Every 8 Weeks Features Understanding the Challenges Facing Long-Term Survivors Her Selfies of Cellulite Counter the Stigma of Aging and HIV People With History of Injecting Drugs Should Not Be Denied Hepatitis C Treatment “We Weren’t Expected to Live This Long” Tracking the Coronavirus Epidemic From Wuhan to the World Opinions The Secret Determined to Live and Love Persistence Can Make a Difference The Ups and Downs of HIV Help Wanted Stay Logged In? You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost. Continue Log out × You Have Been Logged Out Click here to log back in. OKAY...